: Indian Institute of Technology (IIT) Hyderabad on Wednesday said its researchers have found a molecule 'AIM4' that shows promise in the treatment of a rare and debilitating neurodegenerative disease called 'Amyotrophic Lateral Sclerosis' (ALS).
ALS, also known as 'Lou Gehrig's disease' is a neurodegenerative disorder that severely affects voluntary movement of muscles and can lead to paralysis and death.
It occurs due to changes in specific genes, which may be triggered by factors such as smoking, exposure to toxins, metals and pesticides, a release fromIITHyderabad said.
The results of this research, performed by a team led by faculty from the Department of Biotechnology, and Department of Chemistry, IIT Hyderabad, has recently been published in the peer-reviewedInternational Journal of Biological Macromolecules, it said.
According to the release, there are no drugs available at present to cure ALS and treatment options are limited to two drugs only for management of the condition.
Elaborating on this research, Associate Professor Basant Kumar Patel said,"One of the causes of ALS is the alterations in the genes that code for a critical protein called TDP-43."
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
